Pages that link to "Q80467279"

The following pages link to Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study (Q80467279):

Displaying 28 items.

• Pharmacokinetics and pharmacodynamics of danaparoid during continuous venovenous hemofiltration: a pilot study (Q24642002) (← links)
• Renal replacement therapy in acute kidney injury: controversy and consensus (Q26998864) (← links)
• Clinical review: Patency of the circuit in continuous renal replacement therapy (Q33375906) (← links)
• Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments (Q33399961) (← links)
• Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates (Q33612746) (← links)
• Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). (Q33752736) (← links)
• Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial (Q34169048) (← links)
• Year in review in Intensive Care Medicine, 2007. I. Experimental studies. Clinical studies: brain injury and neurology, renal failure and endocrinology (Q36432140) (← links)
• Good-bye CRRT, here comes SLED? ... not so fast! (Q36902623) (← links)
• Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. (Q37036404) (← links)
• Bleeding and thrombotic complications of kidney disease (Q37923002) (← links)
• Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy (Q38463548) (← links)
• Low-molecular weight heparin infusion as anticoagulation for haemodialysis (Q38835775) (← links)
• Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients (Q43060805) (← links)
• Protamine neutralisation of low molecular weight heparins and their oligosaccharide components (Q47411112) (← links)
• The Japanese Clinical Practice Guideline for acute kidney injury 2016 (Q58787383) (← links)
• Anemia, Blood Transfusion, and Filter Life Span in Critically Ill Patients Requiring Continuous Renal Replacement Therapy for Acute Kidney Injury: A Case-Control Study (Q64234936) (← links)
• CRRT - still far from being a standardised BEST treatment? (Q80532826) (← links)
• Survival benefit with regional anticoagulation with citrate in CRRT: the end of a myth? (Q82836424) (← links)
• Nafamostat Mesilate as an Anticoagulant during Continuous Veno-Venous Hemodialysis: A Three-Year Retrospective Cohort Study (Q84590488) (← links)
• Section 5: Dialysis Interventions for Treatment of AKI (Q87393346) (← links)
• [Regional citrate anticoagulation in renal replacement therapy in the intensive care station : Recommendations from the renal section of the DGIIN, ÖGIAIN and DIVI] (Q88600925) (← links)
• Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy (Q90268200) (← links)
• The Japanese clinical practice guideline for acute kidney injury 2016 (Q90435250) (← links)
• Continuous Renal Replacement Therapy: Who, When, Why, and How (Q91857749) (← links)
• Renal Replacement Therapy in the Critical Care Setting (Q92512580) (← links)
• References (Q93609063) (← links)
• Management of acute kidney injury in patients with COVID-19 (Q94952222) (← links)